Lovell T, Dewling H, Li C, Lee H, Gordon C, Kocincova D
bioRxiv. 2025; .
PMID: 39829757
PMC: 11741280.
DOI: 10.1101/2025.01.10.632212.
Andronov L, Han M, Zhu Y, Balaji A, Roy A, Barentine A
Nat Commun. 2024; 15(1):4644.
PMID: 38821943
PMC: 11143195.
DOI: 10.1038/s41467-024-48991-x.
Kuzikov M, Reinshagen J, Wycisk K, Corona A, Esposito F, Malune P
Virus Res. 2024; 343:199356.
PMID: 38490582
PMC: 10958470.
DOI: 10.1016/j.virusres.2024.199356.
Liao Y, Wang H, Liao H, Sun Y, Tan L, Song C
Front Microbiol. 2024; 14:1291761.
PMID: 38328580
PMC: 10847374.
DOI: 10.3389/fmicb.2023.1291761.
Zeng H, Gao X, Xu G, Zhang S, Cheng L, Xiao T
Infect Med (Beijing). 2023; 1(1):7-16.
PMID: 38074973
PMC: 8868009.
DOI: 10.1016/j.imj.2021.12.004.
Nanoscale cellular organization of viral RNA and proteins in SARS-CoV-2 replication organelles.
Andronov L, Han M, Zhu Y, Balaji A, Roy A, Barentine A
bioRxiv. 2023; .
PMID: 37986994
PMC: 10659379.
DOI: 10.1101/2023.11.07.566110.
A systematic review of RdRp of SARS-CoV-2 through artificial intelligence and machine learning utilizing structure-based drug design strategy.
Imtiaz F, Pasha M
Turk J Chem. 2023; 46(3):583-594.
PMID: 37720604
PMC: 10503974.
DOI: 10.55730/1300-0527.3355.
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.
Kakavandi S, Zare I, Vaezjalali M, Dadashi M, Azarian M, Akbari A
Cell Commun Signal. 2023; 21(1):110.
PMID: 37189112
PMC: 10183699.
DOI: 10.1186/s12964-023-01104-5.
Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19.
Aleebrahim-Dehkordi E, Ghoshouni H, Koochaki P, Esmaili-Dehkordi M, Aleebrahim E, Chichagi F
J Mol Struct. 2023; 1287:135642.
PMID: 37131962
PMC: 10131750.
DOI: 10.1016/j.molstruc.2023.135642.
Drug-Repurposing Screening Identifies a Gallic Acid Binding Site on SARS-CoV-2 Non-structural Protein 7.
Gu Y, Liu M, Staker B, Buchko G, Quinn R
ACS Pharmacol Transl Sci. 2023; 6(4):578-586.
PMID: 37082753
PMC: 10111621.
DOI: 10.1021/acsptsci.2c00225.
Can Probiotics, Particularly UCO-979C and UCO-25A, Be Preventive Alternatives against SARS-CoV-2?.
Valdebenito-Navarrete H, Fuentes-Barrera V, Smith C, Salas-Burgos A, A Zuniga F, Gomez L
Biology (Basel). 2023; 12(3).
PMID: 36979076
PMC: 10045641.
DOI: 10.3390/biology12030384.
Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene.
Takada K, Ueda M, Shichinohe S, Kida Y, Ono C, Matsuura Y
iScience. 2023; 26(3):106210.
PMID: 36811085
PMC: 9933857.
DOI: 10.1016/j.isci.2023.106210.
Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex.
Yin X, Popa H, Stapon A, Bouda E, Garcia-Diaz M
J Mol Biol. 2023; 435(5):167973.
PMID: 36690070
PMC: 9854147.
DOI: 10.1016/j.jmb.2023.167973.
Bats-associated beta-coronavirus detection and characterization: First report from Pakistan.
Rahman S, Ullah S, Shinwari Z, Ali M
Infect Genet Evol. 2022; 108:105399.
PMID: 36584905
PMC: 9793958.
DOI: 10.1016/j.meegid.2022.105399.
SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis.
Guo S, Lei X, Chang Y, Zhao J, Wang J, Dong X
Signal Transduct Target Ther. 2022; 7(1):400.
PMID: 36575184
PMC: 9793359.
DOI: 10.1038/s41392-022-01239-w.
The Connection between Gut and Lung Microbiota, Mast Cells, Platelets and SARS-CoV-2 in the Elderly Patient.
Traina G
Int J Mol Sci. 2022; 23(23).
PMID: 36499222
PMC: 9740794.
DOI: 10.3390/ijms232314898.
Immunoinformatics-Based Identification of B and T Cell Epitopes in RNA-Dependent RNA Polymerase of SARS-CoV-2.
Ahmad Mir S, Alaidarous M, Alshehri B, Dukhyil A, Banawas S, Madkhali Y
Vaccines (Basel). 2022; 10(10).
PMID: 36298525
PMC: 9611076.
DOI: 10.3390/vaccines10101660.
Impact of the New Coronavirus Infection on the Immune System of Children and Adolescents in the Region of the Russian Federation.
Kostarev S, Komyagina O, Fayzrakhmanov R, Kurushin D, Tatarnikova N, Novikova Kochetova O
Int J Environ Res Public Health. 2022; 19(20).
PMID: 36294250
PMC: 9603771.
DOI: 10.3390/ijerph192013669.
Exploring the Targets of Novel Corona Virus and Docking-based Screening of Potential Natural Inhibitors to Combat COVID-19.
Dey R, Samadder A, Nandi S
Curr Top Med Chem. 2022; 22(29):2410-2434.
PMID: 36281864
DOI: 10.2174/1568026623666221020163831.
Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp).
Meng W, Guo S, Cao S, Shuda M, Robinson-McCarthy L, McCarthy K
J Med Virol. 2022; 95(1):e28246.
PMID: 36271490
PMC: 9874566.
DOI: 10.1002/jmv.28246.